Costales Anthony B, Eifel Patricia J, Deavers Michael T, Frumovitz Michael, Schmeler Kathleen M
Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gynecol Oncol Case Rep. 2012 May 9;2(3):97-9. doi: 10.1016/j.gynor.2012.05.001. eCollection 2012.
► Recurrent invasive adenocarcinoma after definitive therapy for AIS is a rare occurrence. ► Because of its unpredictable nature, AIS requires long-term and close surveillance.
► 对原位腺癌进行确定性治疗后复发性浸润性腺癌是一种罕见情况。
► 由于其性质不可预测,原位腺癌需要长期密切监测。